![]() ![]() The treatment regimen is a topical application and may be used “as needed” or on a periodic basis and is suitable for use by women 18 and over, particularly those afflicted with vestibulodynia. In premenopausal women, GTO compounds can safely be used in conjunction with birth control medications. ![]() GTO compounds are safe for women for whom estrogens are contraindicated. GTO compounds are safe and effective alternatives to, or may be prescribed in combination with, estrogens or other hormones used to treat genitourinary syndrome of menopause. Moreover, this drug has been used for over 20 years by tens of thousands of patients ![]() The GTO compounds are based on a sinecatechins ointment which is a previously approved FDA botanical drug for a different indication that has Phase IV safety data. The result of this effort has been the development, testing and patenting of several non-hormonal compound formulations which effectively treat these conditions and provide other sexual health benefits such as sexual arousal, lubrication, and intensity of orgasm, thus leading to a fuller and more satisfying sexual life and well-being. Since 2014, GTO has focused its efforts on developing a safe and efficacious topical treatment for certain painful female sexual disorders including vestibulodynia and dyspareunia which constitute the main causes of sexual pain. GTO Pharma, LLC is a New York–based drug development company. Nine out of ten postmenopausal women with sexual pain choose not to use estrogens. The problem is most acute among postmenopausal women about 20 million of which report painful sex. This presents a problem for both these women and their partners. suffer from sexual pain, which in most cases results in loss of sexual arousal, difficulty achieving satisfying orgasms and low sexual desire. It is estimated that between 80 and 200 million women in the U.S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |